A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer
Clinical trial NCT06145412 · COMPLETED
Trial details
- NCT number
- NCT06145412
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2026-08-04
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.